XML 14 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Income Statement [Abstract]        
Net sales $ 2,255 $ 2,109 $ 6,640 $ 6,031
Cost of sales 1,716 1,613 5,007 4,766
Gross profit 539 496 1,633 1,265
Selling, general and administrative expenses 114 98 337 298
Amortization of Intangibles 24 27 75 82
Transaction and integration-related costs 5 7 20 23
Income (loss) from operations 396 364 1,201 862
Other income (expense)        
Interest expense (28) (40) (96) (119)
Other income, net 23 4 53 13
Income before income taxes 391 328 1,158 756
Provision for income taxes 73 109 255 233
Net income 318 219 903 523
Net income attributable to noncontrolling interests 10 8 30 21
Net income attributable to Westlake Chemical Corporation $ 308 $ 211 $ 873 $ 502
Earnings per common share attributable to Westlake Chemical Corporation:        
Basic (usd per share) $ 2.36 $ 1.62 $ 6.70 $ 3.87
Diluted (usd per share) $ 2.35 $ 1.61 $ 6.67 $ 3.85
Weighted average common shares outstanding:        
Basic (in shares) 129,427,328 129,069,186 129,512,097 129,033,597
Diluted (in shares) 130,052,292 129,888,968 130,183,201 129,789,965